BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology. 2009;137:297-308, 308.e1-4. [PMID: 19208365 DOI: 10.1053/j.gastro.2009.01.068] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Newton RC, Scherle PA. Development of c-MET pathway inhibitors. Expert Opin Investig Drugs 2011;20:1225-41. [PMID: 21740293 DOI: 10.1517/13543784.2011.600687] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
2 Tacke F, Weiskirchen R. [Liver fibrosis - pathogenesis and novel therapeutic approaches]. Internist (Berl). 2010;51:21-29. [PMID: 20012930 DOI: 10.1007/s00108-009-2419-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
3 Desole C, Gallo S, Vitacolonna A, Vigna E, Basilico C, Montarolo F, Zuppini F, Casanova E, Miggiano R, Ferraris DM, Bertolotto A, Comoglio PM, Crepaldi T. Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor. Front Immunol 2021;12:775151. [PMID: 34925346 DOI: 10.3389/fimmu.2021.775151] [Reference Citation Analysis]
4 Saito T, Kotani T, Suzuki K. Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice. Sci Rep 2020;10:19019. [PMID: 33149192 DOI: 10.1038/s41598-020-76034-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Sato H, Imamura R, Suga H, Matsumoto K, Sakai K. Cyclic Peptide-Based Biologics Regulating HGF-MET. Int J Mol Sci 2020;21:E7977. [PMID: 33121208 DOI: 10.3390/ijms21217977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Hong TS, Grassberger C, Yeap BY, Jiang W, Wo JY, Goyal L, Clark JW, Crane CH, Koay EJ, Dima S, Eyler CE, Popescu I, DeLaney TF, Zhu AX, Duda DG. Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy. NPJ Precis Oncol 2018;2:22. [PMID: 30374460 DOI: 10.1038/s41698-018-0065-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
7 Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol. 2011;26 Suppl 1:188-202. [PMID: 21199531 DOI: 10.1111/j.1440-1746.2010.06549.x] [Cited by in Crossref: 281] [Cited by in F6Publishing: 270] [Article Influence: 25.5] [Reference Citation Analysis]
8 Schwabe RF, Tabas I, Pajvani UB. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. Gastroenterology 2020;158:1913-28. [PMID: 32044315 DOI: 10.1053/j.gastro.2019.11.311] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 23.5] [Reference Citation Analysis]
9 Marquardt JU, Seo D, Gómez-Quiroz LE, Uchida K, Gillen MC, Kitade M, Kaposi-Novak P, Conner EA, Factor VM, Thorgeirsson SS. Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways. Biochim Biophys Acta. 2012;1822:942-951. [PMID: 22386877 DOI: 10.1016/j.bbadis.2012.02.012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
10 Sakai K, Aoki S, Matsumoto K. Hepatocyte growth factor and Met in drug discovery. J Biochem. 2015;157:271-284. [PMID: 25770121 DOI: 10.1093/jb/mvv027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
11 Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:588-610. [PMID: 20551596 DOI: 10.2183/pjab.86.588] [Cited by in Crossref: 261] [Cited by in F6Publishing: 246] [Article Influence: 23.7] [Reference Citation Analysis]
12 He Y, Long J, Zhong W, Fu Y, Li Y, Lin S. Sustained endoplasmic reticulum stress inhibits hepatocyte proliferation via downregulation of c-Met expression. Mol Cell Biochem 2014;389:151-8. [PMID: 24390087 DOI: 10.1007/s11010-013-1936-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
13 Imamura R, Matsumoto K. Hepatocyte growth factor in physiology and infectious diseases. Cytokine 2017;98:97-106. [PMID: 28094206 DOI: 10.1016/j.cyto.2016.12.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
14 Ramadori P, Drescher H, Erschfeld S, Fragoulis A, Kensler TW, Wruck CJ, Cubero FJ, Trautwein C, Streetz KL, Kroy DC. Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH. Oxid Med Cell Longev 2017;2017:3420286. [PMID: 28676836 DOI: 10.1155/2017/3420286] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
15 Kim J, Jung Y. Potential role of thymosin Beta 4 in liver fibrosis. Int J Mol Sci 2015;16:10624-35. [PMID: 26006229 DOI: 10.3390/ijms160510624] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
16 Liu Z, Li Q, Shen R, Ci L, Wan Z, Shi J, Huang Q, Yang X, Zhang M, Yang H, Sun R, Wang Z, Huang F, Lu T, Fei J. Betaine/GABA transporter-1 (BGT-1) deficiency in mouse prevents acute liver failure in vivo and hepatocytes apoptosis in vitro. Biochim Biophys Acta Mol Basis Dis 2020;1866:165634. [PMID: 31830527 DOI: 10.1016/j.bbadis.2019.165634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Addante A, Roncero C, Almalé L, Lazcanoiturburu N, García-Álvaro M, Fernández M, Sanz J, Hammad S, Nwosu ZC, Lee SJ, Fabregat I, Dooley S, Ten Dijke P, Herrera B, Sánchez A. Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury. Liver Int 2018;38:1664-75. [PMID: 29751359 DOI: 10.1111/liv.13879] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
18 Kojima S, Kuo TF, Tatsukawa H. Regulation of transglutaminase-mediated hepatic cell death in alcoholic steatohepatitis and non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2012;27 Suppl 2:52-7. [PMID: 22320917 DOI: 10.1111/j.1440-1746.2011.07009.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kucharz J, Dumnicka P, Kusnierz-cabala B, Demkow T, Wiechno P. The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC). Med Oncol 2019;36. [DOI: 10.1007/s12032-018-1239-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Xu Q, Nakayama M, Suzuki Y, Sakai K, Nakamura T, Sakai Y, Matsumoto K. Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expression. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;302:G420-9. [DOI: 10.1152/ajpgi.00216.2011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
21 Jin X, Zimmers TA, Zhang Z, Koniaris LG. Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy. Dig Dis Sci 2019;64:93-101. [DOI: 10.1007/s10620-018-5312-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Gómez-quiroz L, Gutiérrez-ruiz M, Marquardt J, Factor V, Thorgeirsson S. Redox Regulation by HGF/c-Met in Liver Disease. Liver Pathophysiology. Elsevier; 2017. pp. 375-87. [DOI: 10.1016/b978-0-12-804274-8.00029-1] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Crestani B, Marchand-Adam S, Quesnel C, Plantier L, Borensztajn K, Marchal J, Mailleux A, Soler P, Dehoux M. Hepatocyte growth factor and lung fibrosis. Proc Am Thorac Soc. 2012;9:158-163. [PMID: 22802291 DOI: 10.1513/pats.201202-018aw] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
24 Tang N, Xu S, Song T, Qiu Y, He J, Fu X. Zinc finger protein 91 accelerates tumour progression by activating β-catenin signalling in pancreatic cancer. Cell Prolif 2021;54:e13031. [PMID: 33755268 DOI: 10.1111/cpr.13031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Kim J, Jung Y. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells. Vitam Horm. 2016;102:121-149. [PMID: 27450733 DOI: 10.1016/bs.vh.2016.04.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
26 Cai H, Lan X, Li A, Zhou Y, Sun J, Lei C, Zhang C, Chen H. SNPs of bovine HGF gene and their association with growth traits in Nanyang cattle. Res Vet Sci 2013;95:483-8. [PMID: 23632198 DOI: 10.1016/j.rvsc.2013.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
27 Ishikawa T, Factor VM, Marquardt JU, Raggi C, Seo D, Kitade M, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology. 2012;55:1215-1226. [PMID: 22095660 DOI: 10.1002/hep.24796] [Cited by in Crossref: 121] [Cited by in F6Publishing: 114] [Article Influence: 12.1] [Reference Citation Analysis]
28 Kroy DC, Schumacher F, Ramadori P, Hatting M, Bergheim I, Gassler N, Boekschoten MV, Müller M, Streetz KL, Trautwein C. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice. J Hepatol 2014;61:883-90. [PMID: 24845607 DOI: 10.1016/j.jhep.2014.05.019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
29 Tag CG, Weiskirchen S, Hittatiya K, Tacke F, Tolba RH, Weiskirchen R. Induction of experimental obstructive cholestasis in mice. Lab Anim. 2015;49:70-80. [PMID: 25835740 DOI: 10.1177/0023677214567748] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
30 Yan M, Wang H, Wang Q, Zhang Z, Zhang C. Allosteric inhibition of c-Met kinase in sub-microsecond molecular dynamics simulations induced by its inhibitor, tivantinib. Phys Chem Chem Phys 2016;18:10367-74. [DOI: 10.1039/c5cp07001e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
31 Tuñon MJ, San Miguel B, Crespo I, Riezu-Boj JI, Larrea E, Alvarez M, González I, Bustos M, González-Gallego J, Prieto J. Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin. J Virol 2011;85:13124-32. [PMID: 21976657 DOI: 10.1128/JVI.05725-11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
32 Cai H, Zhou Y, Jia W, Zhang B, Lan X, Lei C, Fang X, Chen H. Effects of SNPs and alternative splicing within HGF gene on its expression patterns in Qinchuan cattle. J Anim Sci Biotechnol 2015;6:55. [PMID: 26702356 DOI: 10.1186/s40104-015-0059-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
33 Strnad P, Omary MB. Transglutaminase cross-links Sp1-mediated transcription to ethanol-induced liver injury. Gastroenterology 2009;136:1502-5. [PMID: 19318103 DOI: 10.1053/j.gastro.2009.03.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Tang G, Seume N, Häger C, Kumstel S, Abshagen K, Bleich A, Vollmar B, Talbot SR, Zhang X, Zechner D. Comparing distress of mouse models for liver damage. Sci Rep 2020;10:19814. [PMID: 33188220 DOI: 10.1038/s41598-020-76391-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Drescher HK, Schumacher F, Schenker T, Baues M, Lammers T, Hieronymus T, Trautwein C, Streetz KL, Kroy DC. c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types. Oxid Med Cell Longev 2018;2018:6957497. [PMID: 30538805 DOI: 10.1155/2018/6957497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Tatsukawa H, Kojima S. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis. Cell Biol Int 2010;34:325-34. [DOI: 10.1042/cbi20090130] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
37 Kodama T, Takehara T, Hikita H, Shimizu S, Li W, Miyagi T, Hosui A, Tatsumi T, Ishida H, Tadokoro S. Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice. Gastroenterology. 2010;138:2487-298, 2487-298. [PMID: 20206174 DOI: 10.1053/j.gastro.2010.02.054] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
38 Tatsukawa H, Furutani Y, Hitomi K, Kojima S. Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death. Cell Death Dis 2016;7:e2244. [PMID: 27253408 DOI: 10.1038/cddis.2016.150] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 12.5] [Reference Citation Analysis]
39 Matsumoto K, Funakoshi H, Takahashi H, Sakai K. HGF-Met Pathway in Regeneration and Drug Discovery. Biomedicines 2014;2:275-300. [PMID: 28548072 DOI: 10.3390/biomedicines2040275] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
40 Giebeler A, Streetz KL, Soehnlein O, Neumann U, Wang JM, Brandenburg LO. Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation. PLoS One 2014;9:e100522. [PMID: 24956481 DOI: 10.1371/journal.pone.0100522] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
41 Gomez-Quiroz LE, Seo D, Lee YH, Kitade M, Gaiser T, Gillen M, Lee SB, Gutierrez-Ruiz MC, Conner EA, Factor VM, Thorgeirsson SS, Marquardt JU. Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress. Toxicology 2016;361-362:39-48. [PMID: 27394961 DOI: 10.1016/j.tox.2016.07.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
42 Lee SJ, Kim KH, Park KK. Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition. World J Hepatol 2014; 6(4): 207-216 [PMID: 24799989 DOI: 10.4254/wjh.v6.i4.207] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
43 Aguilar-Valenzuela R, Carlsen ED, Liang Y, Soong L, Sun J. Hepatocyte growth factor in dampening liver immune-mediated pathology in acute viral hepatitis without compromising antiviral activity. J Gastroenterol Hepatol 2014;29:878-86. [PMID: 24224701 DOI: 10.1111/jgh.12456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
44 Simone BA, Ly D, Savage JE, Hewitt SM, Dan TD, Ylaya K, Shankavaram U, Lim M, Jin L, Camphausen K, Mitchell JB, Simone NL. microRNA alterations driving acute and late stages of radiation-induced fibrosis in a murine skin model. Int J Radiat Oncol Biol Phys 2014;90:44-52. [PMID: 24986745 DOI: 10.1016/j.ijrobp.2014.05.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
45 Takahashi K, Murata S, Fukunaga K, Ohkohchi N. Human platelets inhibit liver fibrosis in severe combined immunodeficiency mice. World J Gastroenterol 2013; 19(32): 5250-5260 [PMID: 23983427 DOI: 10.3748/wjg.v19.i32.5250] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
46 Liu X, Newton RC, Scherle PA. Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends Mol Med. 2010;16:37-45. [PMID: 20031486 DOI: 10.1016/j.molmed.2009.11.005] [Cited by in Crossref: 129] [Cited by in F6Publishing: 126] [Article Influence: 9.9] [Reference Citation Analysis]
47 Santamaría E, Rodríguez-Ortigosa CM, Uriarte I, Latasa MU, Urtasun R, Alvarez-Sola G, Bárcena-Varela M, Colyn L, Arcelus S, Jiménez M, Deutschmann K, Peleteiro-Vigil A, Gómez-Cambronero J, Milkiewicz M, Milkiewicz P, Sangro B, Keitel V, Monte MJ, Marin JJG, Fernández-Barrena MG, Ávila MA, Berasain C. The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis. Hepatology 2019;69:1632-47. [PMID: 30411380 DOI: 10.1002/hep.30348] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
48 Granito A, Guidetti E, Gramantieri L. c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma. J Hepatocell Carcinoma 2015;2:29-38. [PMID: 27508192 DOI: 10.2147/JHC.S77038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
49 Al-Salihi M, Bornikoel A, Zhuang Y, Stachura P, Scheller J, Lang KS, Lang PA. The role of ADAM17 during liver damage. Biol Chem 2021;402:1115-28. [PMID: 34192832 DOI: 10.1515/hsz-2021-0149] [Reference Citation Analysis]
50 Li J, Chanda D, Shiri-Sverdlov R, Neumann D. MSP: an emerging player in metabolic syndrome. Cytokine Growth Factor Rev 2015;26:75-82. [PMID: 25466635 DOI: 10.1016/j.cytogfr.2014.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
51 Jin X, Zimmers TA, Jiang Y, Milgrom DP, Zhang Z, Koniaris LG. Meloxicam increases epidermal growth factor receptor expression improving survival after hepatic resection in diet-induced obese mice. Surgery 2018;163:1264-71. [PMID: 29361369 DOI: 10.1016/j.surg.2017.11.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Giordano S, Columbano A. Met as a therapeutic target in HCC: facts and hopes. J Hepatol. 2014;60:442-452. [PMID: 24045150 DOI: 10.1016/j.jhep.2013.09.009] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 9.6] [Reference Citation Analysis]
53 Alison MR, Nicholson LJ, Lin WR. Chronic inflammation and hepatocellular carcinoma. Recent Results Cancer Res 2011;185:135-48. [PMID: 21822824 DOI: 10.1007/978-3-642-03503-6_8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
54 Bekheet SH. Morphine sulphate induced histopathological and histochemical changes in the rat liver. Tissue Cell 2010;42:266-72. [PMID: 20655561 DOI: 10.1016/j.tice.2010.06.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
55 Allen J, Zhang J, Quickel MD, Kennett M, Patterson AD, Hankey-Giblin PA. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model. J Proteome Res 2018;17:3268-80. [PMID: 30091925 DOI: 10.1021/acs.jproteome.8b00379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
56 Giebeler A, Brandenburg L, Kaldenbach M, Erschfeld S, Wasmuth H, Wruck C, Trautwein C, Streetz KL. Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation. Lab Invest 2012;92:1726-37. [DOI: 10.1038/labinvest.2012.122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
57 Kojima S, Kuo TF, Tatsukawa H, Hirose S. Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways. Dig Dis 2010;28:715-21. [PMID: 21525755 DOI: 10.1159/000324278] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
58 Scheving LA, Zhang X, Threadgill DW, Russell WE. Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2016;311:G807-16. [PMID: 27586651 DOI: 10.1152/ajpgi.00423.2015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]